Biological effects of and responses to exposure to electrophilic environmental chemicals

Journal of Health Science

Volumn 54, Issue 3, 2008, Pages 267-272

  Sumi, Daigo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Arsenic; Electrophile; Methylmercury; Polycyclic aromatic hydrocarbon

Indexed keywords

1,2 NAPHTHOQUINONE; ARSENIC DERIVATIVE; DNA; ENVIRONMENTAL CHEMICAL; GROUND WATER; METHYLMERCURY; PROTEIN;

ATMOSPHERE; BIOLOGY; CHEMICAL INTERACTION; ELECTRIC ACTIVITY; ENVIRONMENTAL EXPOSURE; MACROMOLECULE; SHORT SURVEY; WATER CONTAMINATION;

EID: 44849093183     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.54.267     Document Type: Short Survey

References (34)

1. Lohse, D. L., Denu, J. M., Santoro, N. and Dixon, J. E. (1997) Roles of aspartic acid-181 and serine-222 in intermediate formation and hydrolysis of the mammalian protein-tyrosine-phosphatase PTP1. Biochemistry, 36, 4568-4575.
2. Li, H., Hanson, C., Fuchs, J. A., Woodward, C. and Thomas, G. J., Jr. (1993) Determination of the pKa values of active-center cysteines, cysteines-32 and -35, in Escherichia coli thioredoxin by Raman spectroscopy. Biochemistry, 32, 5800-5808.
3. Srinivasan, U., Mieyal, P. A. and Mieyal, J. J. (1997) pH profiles indicative of rate-limiting nucleophilic displacement in thioltransferase catalysis. Biochemistry, 36, 3199-3206.
4. Nordstrom, D. K. (2002) Public health. Worldwide occurrences of arsenic in ground water. Science, 296, 2143-2145.
5. Hayakawa, T., Kobayashi, Y., Cui, X. and Hirano, S. (2005) A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol., 79, 183-191.
6. Styblo, M., Drobna, Z., Jaspers, I., Lin, S. and Thomas, D. J. (2002) The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect., 110 (Suppl 5), 767-771.
7. Pi, J., Horiguchi, S., Sun, Y., Nikaido, M., Shimojo, N., Hayashi, T., Yamauchi, H., Itoh, K., Yamamoto, M., Sun, G., Waalkes, M. P. and Kumagai, Y. (2003) A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radic. Biol. Med., 35, 102-113.
8. Pi, J., Kumagai, Y., Sun, G., Yamauchi, H., Yoshida, T., Iso, H., Endo, A., Yu, L., Yuki, K., Miyauchi, T. and Shimojo, N. (2000) Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic. Biol. Med., 28, 1137-1142.
9. Kumagai, Y. and Pi, J. (2004) Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction. Toxicol. Appl. Pharmacol., 198, 450-457.
10. Sumi, D., Taguchi, K., Sun, Y., Shinkai, Y. and Kumagai, Y. (2005) Monomethylarsonous acid inhibits endothelial nitric oxide synthase. J. Health Sci., 51, 728-730.
11. Hayashi, A., Suzuki, H., Itoh, K., Yamamoto, M. and Sugiyama, Y. (2003) Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem. Biophys. Res. Commun., 310, 824-829.
12. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M. and Nabeshima, Y. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun., 236, 313-322.
13. Vollrath, V., Wielandt, A. M., Iruretagoyena, M. and Chianale, J. (2006) Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem. J., 395, 599-609.
14. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D. and Yamamoto, M. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev., 13, 76-86.
15. Tong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S. and Yamamoto, M. (2007) Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell. Biol., 27, 7511-7521.
16. Kumagai, Y. and Sumi, D. (2007) Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu. Rev. Pharmacol. Toxicol., 47, 243-262.
17. Shinkai, Y., Sumi, D., Fukami, I., Ishii, T. and Kumagai, Y. (2006) Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes. FEBS Lett., 580, 1771-1774.
18. Ishii, K., Tamaoka, A., Otsuka, F., Iwasaki, N., Shin, K., Matsui, A., Rudo, G., Kumagai, Y., Ishii, T., Shoji, S., Ogata, T., Ishizaki, M., Doi, M. and Shimojo, N. (2004) Diphenylarsinic acid poisoning from chemical weapons in Kamisu, Japan. Ann. Neurol., 56, 741-745.
19. Sumi, D., Manji, A., Shinkai, Y., Toyama, T. and Kumagai, Y. (2007) Activation of the Nrf2 pathway, but decreased gamma-glutamylcysteine synthetase heavy subunit chain levels and caspase-3-dependent apoptosis during exposure of primary mouse hepatocytes to diphenylarsinic acid. Toxicol. Appl. Pharmacol., 223, 218-224.
20. Simmons-Willis, T. A., Koh, A. S., Clarkson, T. W. and Ballatori, N. (2002) Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem. J., 367, 239-246.
21. Simpson, R. B. (1961) Assosiation constants of methylmercury with sulfhydryl and other bases. J. Am. Chem. Soc., 83, 4711-4717.
22. Carty, A. J. and Malone, S. F. (1979) The chemistry of mercury in biological systems. In The Biogeochemistry of Mercury in the Environment (Nriagu, J. O., Ed.), Elsevier, Amsterdam, pp. 433-470.
23. Clarkson, T. W. (1997) The toxicology of mercury. Crit. Rev. Clin. Lab. Sci., 34, 369-403.
24. Fujiyama, J., Hirayama, K. and Yasutake, A. (1994) Mechanism of methylmercury efflux from cultured astrocytes. Biochem. Pharmacol., 47, 1525-1530.
25. Toyama, T., Sumi, D., Shinkai, Y., Yasutake, A., Taguchi, K., Tong, K. I., Yamamoto, M. and Kumagai, Y. (2007) Cytoprotective role of Nrf2/Keap1 system in methylmercury toxicity. Biochem. Biophys. Res. Commun., 363, 645-650.
26. 2.5. Aerosol Sci. Technol., 38, 1-14.
27. Kim, E. H. and Surh, Y. J. (2006) 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem. Pharmacol., 72, 1516-1528.
28. Hayden, M. S., West, A. P. and Ghosh, S. (2006) NF-kappaB and the immune response. Oncogene, 25, 6758-6780.
29. Sumi, D. and Kumagai, Y. (2007) Chemical biology of 1,2-naphthoquinone, a novel air pollutant, that affects signal transduction pathways. Yakugaku Zasshi, 127, 1949-1956 (in Japanese).
30. Abate, C., Patel, L., Rauscher, F. J., III and Curran, T. (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science, 249, 1157-1161.
31. Vinson, C., Acharya, A. and Taparowsky, E. J. (2006) Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim. Biophys. Acta., 1759, 4-12.
32. Endo, A., Sumi, D. and Kumagai, Y. C. (2007) 1,2-Naphthoquinone disrupts the function of cAMP response element-binding protein through covalent modification. Biochem. Biophys. Res. Commun., 361, 243-248.
33. Kikuno, S., Taguchi, K., Iwamoto, N., Yamano, S., Cho, A. K., Froines, J. R. and Kumagai, Y. (2006) 1,2-Naphthoquinone activates vanilloid receptor 1 through increased protein tyrosine phosphorylation, leading to contraction of guinea pig trachea. Toxicol. Appl. Pharmacol., 210, 47-54.
34. Iwamoto, N., Sumi, D., Ishii, T., Uchida, K., Cho, A. K., Froines, J. R. and Kumagai, Y. (2007) Chemical knockdown of protein-tyrosine phosphatase 1B by 1,2-naphthoquinone through covalent modification causes persistent transactivation of epidermal growth factor receptor. J. Biol. Chem., 282, 33396-33404.